nach oben

Drug Safety

Erschienen in:

01.06.2005 | Correspondence

Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women

verfasst von: Richard Elliott

Erschienen in: Drug Safety | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Excerpt

I am writing to note a possible concern with the control group used in the study by Wilton et al.[1] on the relative risk of vaginal candidiasis after the use of antibiotics compared with antidepressants. …

Wilton LV, Kollarova M, Heeley E, et al. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 2003; 26(8): 589–97PubMedCrossRef

Lass-Florl C, Dierich MP, Fuchs D, et al. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother 2001; 48(6): 775–9PubMedCrossRef

Lass-Florl C, Ledochowski M, Fuchs D, et al. Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro. FEMS Immunol Med Microbiol 2003; 35(1): 11–5PubMed

Lass-Florl C, Dierich MP, Fuchs D, et al. Antifungal activity against Candida species of the selective serotonin reuptake inhibitor sertraline. Clin Infect Dis 2001; 3(12): E135–6CrossRef

Domenico P, Schwartz S, Cuhna BA. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989; (57): 3778–82PubMed

Roberts D, Cole P. N-acetylcysteine potentiates the antipseudomonas activity of carbenicillin in vitro. J Infect 1981; 3(4): 353–9PubMedCrossRef

Rautelin H, Kosunen TU. Helicobacter pylori and associated gastroduodenal diseases. APMIS 1991; 99(8): 677–95PubMedCrossRef

Baker CA, Desrosiers K, Dolan JW. Propranolol inhibits hyphal development in Candida albicans. Antimicrob Agents Chemother 2002; 46(11): 3617–20PubMedCrossRef

Titel: Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women
verfasst von: Richard Elliott
Publikationsdatum: 01.06.2005
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 6/2005
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200528060-00007

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2005

The Authors’ Reply

Designing Safe Drug Names

Drug-Induced Anaphylaxis

Hormone Replacement Therapy and Risk of Acute Myocardial Infarction

Safety of Drugs Used in Assisted Reproduction Techniques

The Precautionary Principle and Pharmaceutical Risk Management